| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |